Sign Up to like & get
recommendations!
0
Published in 2019 at "Anti-Cancer Drugs"
DOI: 10.1097/cad.0000000000000696
Abstract: Objective All-trans-N-(4-hydroxyphenyl)retinamide or fenretinide (4-HPR) acts by reactive oxygen species (ROS) and dihydroceramides (DHCers). In early-phase clinical trials 4-HPR has achieved complete responses in T-cell lymphomas (TCL) and neuroblastoma (NB) and signals of activity in…
read more here.
Keywords:
hpr;
cytotoxicity;
cis hpr;
activity ... See more keywords